Annual Retained Earnings
-$594.29 M
-$123.43 M-26.21%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual retained earnings is -$594.29 million, with the most recent change of -$123.43 million (-26.21%) on December 31, 2023.
- During the last 3 years, PSTX annual retained earnings has fallen by -$312.41 million (-110.83%).
Performance
PSTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$629.70 M
+$20.23 M+3.11%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly retained earnings is -$629.70 million, with the most recent change of +$20.23 million (+3.11%) on September 30, 2024.
- Over the past year, PSTX quarterly retained earnings has increased by +$20.23 million (+3.11%).
Performance
PSTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PSTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.2% | +3.1% |
| 3 y3 years | -110.8% | -54.2% |
| 5 y5 years | -804.6% | - |
PSTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +46.1% | at low | +54.8% | +3.2% |
| 5 y | 5-year | +290.4% | at low | +313.7% | +3.2% |
| alltime | all time | +2691.4% | at low | +313.7% | +3.2% |
Poseida Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$629.70 M(-3.1%) |
| Jun 2024 | - | -$649.94 M(+5.1%) |
| Mar 2024 | - | -$618.57 M(+4.1%) |
| Dec 2023 | -$594.29 M(+26.2%) | -$594.29 M(+4.5%) |
| Sep 2023 | - | -$568.94 M(+5.9%) |
| Jun 2023 | - | -$537.16 M(+5.4%) |
| Mar 2023 | - | -$509.71 M(+8.3%) |
| Dec 2022 | -$470.86 M(+15.7%) | -$470.86 M(+7.6%) |
| Sep 2022 | - | -$437.54 M(-13.9%) |
| Jun 2022 | - | -$507.95 M(+9.3%) |
| Mar 2022 | - | -$464.92 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -$406.86 M(+44.3%) | -$406.86 M(-0.4%) |
| Sep 2021 | - | -$408.33 M(+11.6%) |
| Jun 2021 | - | -$365.90 M(+14.3%) |
| Mar 2021 | - | -$320.20 M(+13.6%) |
| Dec 2020 | -$281.88 M(+85.2%) | -$281.88 M(+14.7%) |
| Sep 2020 | - | -$245.74 M(+16.3%) |
| Jun 2020 | - | -$211.32 M(+16.8%) |
| Mar 2020 | - | -$180.89 M(+18.8%) |
| Dec 2019 | -$152.22 M(+131.7%) | -$152.22 M |
| Dec 2018 | -$65.69 M(+208.6%) | - |
| Dec 2017 | -$21.29 M | - |
FAQ
- What is Poseida Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Poseida Therapeutics?
- What is Poseida Therapeutics annual retained earnings year-on-year change?
- What is Poseida Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly retained earnings year-on-year change?
What is Poseida Therapeutics annual retained earnings?
The current annual retained earnings of PSTX is -$594.29 M
What is the all time high annual retained earnings for Poseida Therapeutics?
Poseida Therapeutics all-time high annual retained earnings is -$21.29 M
What is Poseida Therapeutics annual retained earnings year-on-year change?
Over the past year, PSTX annual retained earnings has changed by -$123.43 M (-26.21%)
What is Poseida Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PSTX is -$629.70 M
What is the all time high quarterly retained earnings for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly retained earnings is -$152.22 M
What is Poseida Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PSTX quarterly retained earnings has changed by +$20.23 M (+3.11%)